NO139441C - Fremgangsmaate ved fremstilling av nye leurosinderivater og deres salter - Google Patents

Fremgangsmaate ved fremstilling av nye leurosinderivater og deres salter

Info

Publication number
NO139441C
NO139441C NO740228A NO740228A NO139441C NO 139441 C NO139441 C NO 139441C NO 740228 A NO740228 A NO 740228A NO 740228 A NO740228 A NO 740228A NO 139441 C NO139441 C NO 139441C
Authority
NO
Norway
Prior art keywords
leurosin
procedures
derivatives
salts
preparation
Prior art date
Application number
NO740228A
Other languages
English (en)
Norwegian (no)
Other versions
NO139441B (no
NO740228A (no
Inventor
Karola Jovanovics
Kalman Szasz
Bela Kellner
Laszlo Nemeth
Emil Bittner
Zsuzsa Relle
Eszter Dezseri
Janos Eles
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO740228A publication Critical patent/NO740228A/no
Publication of NO139441B publication Critical patent/NO139441B/no
Publication of NO139441C publication Critical patent/NO139441C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO740228A 1973-02-16 1974-01-24 Fremgangsmaate ved fremstilling av nye leurosinderivater og deres salter NO139441C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI502A HU165986B (US06657057-20031202-C00006.png) 1973-02-16 1973-02-16

Publications (3)

Publication Number Publication Date
NO740228A NO740228A (no) 1974-08-19
NO139441B NO139441B (no) 1978-12-04
NO139441C true NO139441C (no) 1979-03-14

Family

ID=11000914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740228A NO139441C (no) 1973-02-16 1974-01-24 Fremgangsmaate ved fremstilling av nye leurosinderivater og deres salter

Country Status (25)

Country Link
US (3) US4189432A (US06657057-20031202-C00006.png)
JP (1) JPS5221520B2 (US06657057-20031202-C00006.png)
AT (1) AT332566B (US06657057-20031202-C00006.png)
BE (1) BE811110A (US06657057-20031202-C00006.png)
BG (1) BG21415A3 (US06657057-20031202-C00006.png)
CA (1) CA1029017A (US06657057-20031202-C00006.png)
CH (1) CH592101A5 (US06657057-20031202-C00006.png)
CS (1) CS181737B2 (US06657057-20031202-C00006.png)
DD (1) DD110276A5 (US06657057-20031202-C00006.png)
DE (1) DE2404120C3 (US06657057-20031202-C00006.png)
DK (1) DK138459B (US06657057-20031202-C00006.png)
ES (1) ES423289A1 (US06657057-20031202-C00006.png)
FI (1) FI57760C (US06657057-20031202-C00006.png)
FR (1) FR2218095B1 (US06657057-20031202-C00006.png)
GB (1) GB1412932A (US06657057-20031202-C00006.png)
HU (1) HU165986B (US06657057-20031202-C00006.png)
IL (1) IL43963A (US06657057-20031202-C00006.png)
NL (1) NL159390B (US06657057-20031202-C00006.png)
NO (1) NO139441C (US06657057-20031202-C00006.png)
PL (1) PL88630B1 (US06657057-20031202-C00006.png)
RO (1) RO65486A (US06657057-20031202-C00006.png)
SE (1) SE407687B (US06657057-20031202-C00006.png)
SU (1) SU576951A3 (US06657057-20031202-C00006.png)
YU (1) YU35893B (US06657057-20031202-C00006.png)
ZA (1) ZA741015B (US06657057-20031202-C00006.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (US06657057-20031202-C00006.png) * 1974-12-30 1978-07-21 Anvar
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
HU178706B (en) * 1979-04-23 1982-06-28 Richter Gedeon Vegyeszet Process for preparing bis-indole alkaloids and acid addition salts thereof
FR2651348B1 (US06657057-20031202-C00006.png) * 1989-08-04 1993-01-22 Adir
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US4065457A (en) * 1973-05-19 1977-12-27 Beecham Group Limited 4-Hydroxy-3-nitro-carbostyril compounds

Also Published As

Publication number Publication date
BG21415A3 (US06657057-20031202-C00006.png) 1976-05-20
YU13374A (en) 1981-02-28
DD110276A5 (US06657057-20031202-C00006.png) 1974-12-12
PL88630B1 (en) 1976-09-30
US4189432A (en) 1980-02-19
DE2404120C3 (de) 1978-07-20
ZA741015B (en) 1975-02-26
NO139441B (no) 1978-12-04
JPS5221520B2 (US06657057-20031202-C00006.png) 1977-06-10
DK138459B (da) 1978-09-11
IL43963A (en) 1976-04-30
CA1029017A (en) 1978-04-04
ATA65374A (de) 1976-01-15
NO740228A (no) 1974-08-19
SE407687B (sv) 1979-04-09
US4279916A (en) 1981-07-21
CS181737B2 (en) 1978-03-31
JPS5040599A (US06657057-20031202-C00006.png) 1975-04-14
AU6428274A (en) 1975-07-10
IL43963A0 (en) 1974-05-16
GB1412932A (en) 1975-11-05
ES423289A1 (es) 1976-04-16
RO65486A (ro) 1980-06-15
CH592101A5 (US06657057-20031202-C00006.png) 1977-10-14
DE2404120A1 (de) 1974-08-29
SU576951A3 (ru) 1977-10-15
DE2404120B2 (de) 1977-11-10
AT332566B (de) 1976-10-11
FR2218095A1 (US06657057-20031202-C00006.png) 1974-09-13
US4279915A (en) 1981-07-21
FI57760C (fi) 1980-10-10
FI57760B (fi) 1980-06-30
NL7401416A (US06657057-20031202-C00006.png) 1974-08-20
BE811110A (fr) 1974-05-29
HU165986B (US06657057-20031202-C00006.png) 1974-12-28
FR2218095B1 (US06657057-20031202-C00006.png) 1978-01-06
DK138459C (US06657057-20031202-C00006.png) 1979-02-19
YU35893B (en) 1981-08-31
NL159390B (nl) 1979-02-15

Similar Documents

Publication Publication Date Title
NO793035L (no) Nye jodbenzenderivater og fremgangsmaate for deres fremstilling
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO741170L (no) Fremgangsmåte til fremstilling av 2-arylamino-2-imidazolinderivater samt deres salter.
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE420604B (sv) Forfarande for framstellning av oxazolderivat
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
SE411898B (sv) Analogiforfarande for framstellning av oxamidsyraderivat
SE410856B (sv) Forfarande for framstellning av tetrahydropyridin- och piperidinderivat
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO149134C (no) Analogifremgangsmaate for fremstilling av nye fenoksypropylaminderivater og deres farmasoeytisk akseptable salter
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
NO139441C (no) Fremgangsmaate ved fremstilling av nye leurosinderivater og deres salter
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
NO140135C (no) Fremgangsmaate for fremstilling av d(-)-penicillamin og salter av dette
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat